Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Theralase Technologies Inc. TLTFF


Primary Symbol: V.TLT

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:TLT)

Theralase(R) Closes Non-Brokered Private Placement

Accesswire 6 days ago

Theralase(R) Extends Warrants

Accesswire 8 days ago

Three Canadian small-caps stocks for a contrarian investment

Trevor Abes  October 11, 2024

Latest data from bladder cancer study to propel future growth

Jocelyn Aspa October 10, 2024

Theralase’s bladder cancer drug under investigation in clinical study

Jonathon Brown October 7, 2024

Theralase(R) Provides Update on Bladder Cancer Clinical Study

Accesswire October 7, 2024

Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options

Accesswire September 24, 2024

Theralase(R) Extends Warrants

Accesswire September 19, 2024

Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus

Accesswire September 3, 2024
View More News ››

Opinion & Analysis (TSXV:TLT)

Pharmaceutical company treats bladder cancer with new tech

Ryan Dhillon January 8, 2024

Theralase is raising up to $5.3M to complete bladder cancer study

Coreena Robertson November 6, 2023

For Better or Worse? On the Verge of a New Era in Investing

Stockhouse Editorial April 1, 2021

Buzz on the Bullboards: A Big Picture Look at Small-Cap Opportunities

Stockhouse Editorial February 18, 2021

Buzz on the Bullboards: Tracking the Big Movers of 2020

Stockhouse Editorial December 17, 2020

Buzz on the Bullboards: T’is the Season for a Rebound?

Stockhouse Editorial December 3, 2020
View More Opinion ››

Bullboard Posts (TSXV:TLT)

RE:RE:Went back 17 pages on Dumbles post pages

I've been stalked at grocery stores and gas stations for 7 years by a political mob. Even my cellphone and financial content was...
DeathXray33 - 1 hour ago

RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook

It's totally surreal.  To think that we're sitting next to a soon to be preeminent FDA endosed molecule, potentially...
BlueFranky - 11 hours ago

RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook

Correction... 7)  Achieving efficacy & durability, but at the expense of one or a combination        of...
CancerSlayer - 11 hours ago

RE:RE:RE:RE:RE:RE:RE:2025 Outlook

Certainly....if we were to put a lens on just clinical development stage/progress, being a company with a nearly completed Ph II (&...
CancerSlayer - 11 hours ago

RE:RE:RE:RE:RE:RE:RE:RE:2025 Outlook

The outlook for 2025 is not good it is not better it is the BEST.  My gut feeling, we will get BTD in 2024.  We may even AA...
Infinity - 13 hours ago

RE:RE:RE:RE:RE:RE:RE:2025 Outlook

11000 volume. .285 c after 15 years of  company existence boy that is a good  stuff.Keep pumping boys
Alamir1111 - 13 hours ago
View more Bullboard ››

AJA Health and Wellness Inc.

AJA Health and Wellness Inc.

AJA Health and Wellness Inc. is focused on health and wellness solutions. The Company is engaged in operating a telemedicine ...
View More »